Oncoai
A OncoAI surgiu em 2023 após a sócia fundadora ter finalizado seu doutorado desenvolvendo a predição de recidiva de câncer superficial de bexiga. A proposta era expandir para as neoplasias de mama e pulmão, as duas que mais afetam o Brasil e o mundo. Nossa proposta baseia-se no desenvolvimento de dois produtos: o OncoBreast e o OncoLung que retornam à probabilidade de recidiva a depender do protocolo de tratamento que é oferecido ao paciente visando aumentar sua sobrevida livre de recidiva da doença.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Oncoai
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Oncoai
1 distinct titles indexed · top 1 shown.
- 1co-founder & ceo
Sign up to unlock all 1 contacts at Oncoai
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Oncoai
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.